Affiner les résultats

Langue

Haute école de santé Genève

L'accompagnement infirmier favorisant les formes et ressources des jeunes face à l'infection à Papillomavirus Humain : travail de Bachelor

Battiato, Marina ; Bouvier-Gobalet, Irmeline ; Cennamo, Michaël (Dir.)

Mémoire de bachelor : Haute école de santé Genève, 2021.

Nous avons décidé d'orienter notre travail de Bachelor en soins infirmiers sur une problématique de santé touchant les personnes à risque et souffrant de l'infection à Papillomavirus Humain (HPV). L'infection à Papillomavirus est une problématique actuelle avec une prévalence en augmentation ces dernières années. Une part importante de la population est touchée au moins une fois dans...

Université de Fribourg

The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value

Songane, Mario ; Grossmann, Volker

In: PLOS One, 2021, p. 1-22

Human papillomavirus (HPV) is responsible for almost all of the 570,000 new cases of cervical cancer and approximately 311,000 deaths per year. HPV vaccination is an integral component of the World Health Organization’s (WHO) global strategy to fight the disease. However, high vaccine prices enforced through patent protection are limiting vaccine expansion, particularly in low- and...

Università della Svizzera italiana

Collaborating with complementary and alternative medicine (CAM) providers when writing HPV vaccine review articles

Deml, Michael J. ; Dietrich, Léna G. ; Wingeier, Bernhard ; Etter, Gisela ; Gallmann, Caesar ; Berger, Christoph ; Suggs, L. Suzanne ; Huber, Benedikt M. ; Tarr, Philip E.

In: Journal of clinical medicine, 2020, vol. 9, no. 2, p. 15 p

Novel strategies are needed to address vaccine hesitancy (VH), which correlates with complementary and alternative medicine (CAM). In Switzerland, CAM providers play important roles in vaccine counseling of vaccine hesitant (VH) parents, and traditional vaccination messaging tends to overlook CAM provider perspectives. In the setting of a Swiss national research program on VH, our key strategy ...

Université de Fribourg

The patent buyout price for Human Papilloma Virus (HPV) vaccine and the ratio of R&D costs to the patent value

Songane, Mario ; Grossmann, Volker

(Working Papers SES ; 510)

Human papillomavirus (HPV) is responsible for almost all of the 530,000 new cases of cervical cancer and approximately 266,000 deaths per year. HPV vaccination is an integral component of the World Health Organization’s global strategy to fight the disease. However, high vaccine prices enforced through patent protection are limiting vaccine expansion, particularly in low- and middle-income...